ACTO

JUNE 10, 2024

Founded in 2010, 4DS disrupted the industry with their technology and approach by shifting commercial training from a once-and-done exercise to a continuous learning technique to impact field sales performance. “Our 4DS was a pioneer in the evolution of commercial learning in the life sciences industry,” said Parth Khanna, CEO of ACTO.

Science 52

Science Pharmaceuticals Marketing 52

FDA Law Blog: Biosimilars

APRIL 16, 2024

Vanda Pharmaceuticals, Inc. Under the Medicaid Drug Rebate statute, a pharmaceutical manufacturer whose drug prices increase faster than the rate of inflation must pay additional per-unit rebates to the program. Vanda Pharmaceuticals, Inc. Centers for Medicare and Medicaid Servs., 23-1457 (4th Cir. NDA or BLA drugs).

Drugs 59

Drugs Pharmaceuticals Regulations 59

FDA Law Blog: Biosimilars

MAY 30, 2024

Kirschenbaum — Last week, the United States Court of Appeals for the District of Columbia ruled that Section 340B of the Public Health Service Act does not prohibit pharmaceutical manufacturers from imposing conditions on the distribution of discounted drugs to covered entities in the program. Novartis Pharmaceuticals v.

Pharmacy 59

Pharmacy Pharmaceuticals Drugs Government 59

NIH Director's Blog: Drug Development

FEBRUARY 27, 2018

In an analysis of more than 28 million papers in the PubMed.gov database , researchers found NIH contributed to published research that was associated with every single one of the 210 new drugs approved by the Food and Drug Administration from 2010 through 2016 [1]. Reference: [1] Contribution of NIH funding to new drug approvals 2010-2016.

Research 52

Research Science FDA Pharmaceutical Companies 52

Drug Target Review

SEPTEMBER 19, 2023

The first successful chip adaptation to a lung model was first described in 2010 by Donald Ingber, a bioengineer at Wyss institute. The first successful chip adaptation to a lung model was first described in 2010 by Donald Ingber, a bioengineer at Wyss institute.

Animal Testing 98

Animal Testing Clinical Trials Pharmaceutical Companies FDA 98

Nvidia Developer: Drug Discovery

NOVEMBER 3, 2021

Whether working in pharmaceuticals, Computational molecular design involves compute-intense calculations that require exceptional processing power. Whether working in pharmaceuticals, biotechnology, agrochemicals, or the fragrance industry, researchers are oftentimes dealing with datasets that encompass millions to billions of compounds.

Drugs 52

Drugs Pharmaceuticals Production Research 52

Drug Target Review

NOVEMBER 1, 2023

Capivasertib originated from a collaboration between my former company Astex Pharmaceuticals and the ICR and was further developed by AstraZeneca. In 2001, he joined Astex Pharmaceuticals in Cambridge where he became an expert in fragment-based drug discovery working on diabetes, thrombotic and oncology drug targets.

Fragment Screening 96

Fragment Screening Biochemical Assays Small Molecule Biophysical Assays 96

The Pharma Data

DECEMBER 10, 2020

Pirozzi now serves as Senior Vice President, Head of Clinical Development and Translational Sciences at Alexion Pharmaceuticals, Inc., positions he assumed in 2020. At Alexion, he is responsible for the development of medicines for rare and devastating diseases in hematology, nephrology, neurology, ophthalmology, and for metabolic syndromes.

Disease 52

Disease Research Doctors Clinical Development 52

The Pharma Data

SEPTEMBER 24, 2020

This allowed Gilead to boost their revenue from June 2007 to December 2010, which violated the federal False Claims Act. This legislation specifically outlaws pharmaceutical companies from offering anything of value to incentivise Medicare patients to buy their drugs. .

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmacy Government Pharmaceuticals 40

The Pharma Data

JANUARY 31, 2021

DeveloGen was acquired by Evotec in 2010. Since 2010, Dr Dohrmann has been serving Evotec as Chief Scientific Officer and Member of the Management Board. At DeveloGen, Dr Dohrmann led the company to become an internationally recognised leader in metabolic diseases.

Science 52

Science Government Medical Schools International 52

Common Sense for Drug Policy Blog

JUNE 6, 2024

2018 ; Llewellyn and Tober 2010; Denham 2019 ). Underground labs can be defined as illicit operations where IPEDs, most commonly anabolics androgenic steroids, are produced from these imported powders outside of registered pharmaceutical manufacture.

Marketing 40

Marketing Drugs Production Pharmaceuticals 40

The Pharma Data

MARCH 15, 2021

Takeda Pharmaceutical Company Limited ( TSE:4502/NYSE:TAK ) (“Takeda”) today announced that Milano Furuta, Takeda’s current global corporate strategy officer and chief of staff, has been appointed as president of the Japan Pharma Business Unit (JPBU) effective April 1, 2021. Masato Iwasaki will transition from the role on March 31, 2021.

Pharmaceutical Companies 52

Pharmaceutical Companies International Pharmaceuticals Production 52

The Pharma Data

JANUARY 4, 2021

Rothenberg took over as Pfizer CMO in January 2019, but spent more than 12 years in total working for the pharmaceutical giant. Habtezion joined Stanford as an assistant professor in December 2010 and also serves as faculty in the Immunology Ph.D. BioSpace reached out to Rothenberg for comment and will update following a response.

Pharma Companies 52

Pharma Companies Clinical Development Clinical Research International 52

The Pharma Data

JUNE 26, 2021

Pradaxa was originally approved in 2010 to reduce the risk of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation. The FDA granted the approval of Pradaxa to Boehringer Ingelheim Pharmaceuticals, Inc. ” Blood clots can be a serious problem in children as well as adults. Source link: [link].

FDA Approval 52

FDA Approval FDA Treatment Pharmaceuticals 52

The Pharma Data

NOVEMBER 19, 2020

Prior to joining Bain in 2010, Retterath was a partner at Monitor Group and head of the New York office. Previously, she was head of Business Development at Cubist Pharmaceuticals. Cogentus Pharmaceuticals, Inc., Retterath joins Spark from Bain & Company, where he served as a partner in the healthcare practice for a decade.

Laboratories 52

Laboratories Research Laboratories Science Organic Chemistry 52

Drug Target Review

AUGUST 9, 2024

Drug formulation is the process of designing and producing a final medicinal product from an active pharmaceutical ingredient (API). Ansel’s Pharmaceutical Dosage Forms and Drug Delivery Systems (9th ed.). Pharmaceutics. What is drug formulation? Popovich, N. G., & Ansel, H. Lippincott Williams & Wilkins.

Science 59

Science Drugs Compliance Drug Development 59

The Pharma Data

MARCH 16, 2021

As a world-leading, research-driven pharmaceutical company, more than 51,000 employees create value through innovation daily for our three business areas: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. The Lieber Institute for Brain Development.

Licensing 52

Licensing Licensing Research Laboratories Treatment 52

The Premier Consulting Blog

APRIL 27, 2023

Then, in 1997, the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) formed the ICH M8 Expert Working Group/Implementation Working Group (EWG/IWG). Premier Consulting has been a trusted eCTD vendor for small to midsize pharmaceutical, biotech, and medical device companies since 1995.

Packaging 52

Packaging FDA International Pharmaceuticals 52

The Pharma Data

JANUARY 12, 2021

From 2010 to 2020, Dr Graham was VP of Strategic Program Direction, Immunology and Inflammation at Regeneron Pharmaceuticals, Inc., Multiple IND’s, NDA/BLA filings and/or defense and multiple successful launches.

Science 52

Science Clinical Development Disease Production 52

National Institute on Drug Abuse: Nora's Blog

MARCH 6, 2025

This challenge may account for part of the reluctance of the pharmaceutical industry to invest in developing new medications aimed at reducing drug use. 2010 Dec;34(12):2022-34. Retrieved March 6, 2025, [link] Falk D, Wang XQ, Liu L, Fertig J, Mattson M, Ryan M, Johnson B, Stout R, Litten RZ. Alcohol Clin Exp Res. doi: 10.1111/j.1530-0277.2010.01290.x.

Treatment 69

Treatment Trials Clinical Trials Drugs 69

FDA Law Blog: Biosimilars

APRIL 3, 2023

Vanda Pharmaceuticals, Inc. In 2010, concerned that manufacturers were making minor changes to a drug merely so that it could be characterized as new covered outpatient drug with an updated baseline AMP, Congress added to the statute an alternative rebate for line extensions of oral dosage form innovator (i.e., MJM-22-977 (Dist.

Drugs 59

Drugs Regulations Production Marketing 59

Drug Target Review

SEPTEMBER 26, 2023

2010 Aug;31(4):331–50. Gaps and challenges in nonclinical assessments of pharmaceuticals: An FDA/CDER perspective on considerations for development of new approach methodologies. Johnstone AFM, Gross GW, Weiss DG, Schroeder OHU, Gramowski A, Shafer TJ. Neurotoxicology. Drug Discov Today. 2009 Sep;14(17–18):876–84. 2023 Mar;139:105345.

Drugs 111

Drugs FDA Disease Animal Testing 111

Eye on FDA

JULY 7, 2020

FDA said they would produce a guidance by the end of 2010, but did not. For some years CDER published its Guidance Agenda to include a guidance on the use of links to third party websites by pharmaceutical companies. One of them was about the appropriate use of links.

FDA 52

FDA Pharmaceutical Companies Doctors Drugs 52

Codon

JUNE 18, 2024

Right) The passage of text from a 2010 review that inspired Mikhail Shapiro to engineer gas vesicles. Voigt, Biotechnology Journal (2010). In 2010, Shapiro picked up a review article and noticed two short paragraphs —included almost as an afterthought—about gas vesicles. 31,500x magnification. Walsby , 1994 & M.

Engineering 70

Engineering Laboratories International Clinical Trials 70

Perficient: Drug Development

JANUARY 25, 2024

This is a disappointing reversal for payers, as the 2010 results showed a nine-point gain compared to the 2003 figure. And 32% rated their interactions as “Poor” (the third-highest in that category, trailing only pharmaceutical companies and nursing homes). Quite frankly … not much. So there’s not much to celebrate in these results.

Nurses 52

Nurses Health Insurance Companies Pharmaceutical Companies Hospitals 52

Agency IQ

OCTOBER 6, 2023

Codes starting with 3 are for facilities conducting activities covered by the EU’s Industrial Emissions Directive (EU) 2010/75 (IED), and codes starting with 4 are for facilities with substances covered by the Seveso III Directive 2012/18/EU. Codes beginning with 1 categorize facilities based on the substances used there (i.e.,

Pharmaceuticals 40

Pharmaceuticals Regulations Production Pharmaceutical Companies 40

Precision for Medicine

JUNE 26, 2023

About Baseline Controls Founded in 2010, Baseline Controls has proven Progress through Performance by demonstrating a commitment to excellence. Baseline Controls serves the pharmaceutical and biotech industries with a focus on process, planning, and priority resulting in the client’s Progress through Performance.

Science 40

Science Small Molecule Clinical Research Engineering 40

The Pharma Data

SEPTEMBER 1, 2020

Established in 2010, SD Biosensor has successfully launched diagnostics of blood glucose, glycated hemoglobin, and cholesterols globally, and with innovative products, are striving to become a leading global in vitro diagnostic company. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. In 2019, Roche invested CHF 11.7

Virus 52

Virus Laboratories Clinical Trials Treatment 52

The Pharma Data

MARCH 5, 2021

This is the sixth FDA approved indication for Actemra/RoActemra since the medicine was launched in the United States in 2010. Actemra/RoActemra is part of a co-development agreement with Chugai Pharmaceutical Co., About the focuSSced Trial. Ltd and has been approved in Japan since April 2005. Source link:[link].

FDA 52

FDA Disease FDA Approval Therapies 52

The Pharma Data

JANUARY 11, 2021

AvantGen’s partners include pharmaceutical, biotech, diagnostic and government entities, many of which are repeat customers. Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. For more information, visit www.avantgen.com.

Licensing 52

Licensing Licensing Therapies Engineering 52

Agency IQ

NOVEMBER 27, 2023

These standards were expected to be established within 30 months, or by March 27, 2010. Many posted comments came from professional pharmacy organizations, trade groups like the Pharmaceutical Research and Manufacturers of America (PhRMA) , and pharmaceutical companies, such a Eli Lilly , Novo Nordisk and Merck.

FDA 40

FDA Science Drugs Regulations 40

Codon

JANUARY 21, 2024

People are hesitant to do this because it's not a particularly flashy disease to research, nor is this population the focus of major pharmaceutical companies. But in 2010, this guy participating in a challenge trial in Oxford committed sexual assault and then ran from the law and was a fugitive, while participating in this study.

Vaccine 126

Vaccine Trials Disease Treatment 126

New Drug Approvals

SEPTEMBER 13, 2024

4] [6] Aticaprant was originally developed by Eli Lilly , was under development by Cerecor for a time, and is now under development by Janssen Pharmaceuticals. [2] 2] It first appeared in the scientific literature in 2010 or 2011. [16] 2] It first appeared in the scientific literature in 2010 or 2011. [16] nM vs. 24.0

Treatment 62

Treatment Clinical Trials Pharmacokinetics Pharmaceuticals 62

Codon

APRIL 9, 2024

Few journal articles were written about the project using her (or anyone’s) name before 2010. Medical research groups were joined by pharmaceutical companies, chemical and spice factories, botany institutes, and insect science institutes. Nobody had an answer.

Drugs 139

Drugs Science Research Doctors 139

Codon

MARCH 24, 2024

This was the founding ethos of Moderna, the mRNA vaccine developer, when it was launched in 2010 by Noubar Afeyan and Doug Cole at Flagship Pioneering. Between the technical uncertainty and the horrendous PR, pharmaceutical companies had little interest in adopting molecular farming technologies. “It was about 6 p.m.

Engineering 87

Engineering Vaccine Production RNA 87

Drug Target Review

APRIL 8, 2024

He was awarded the 2013 Distinguished Alumnus of the Year by the School of Physical Sciences at the University of California, Irvine, was elected to the Association of American Physicians in 2010 and is a member of Phi Beta Kappa and the Alpha Omega Alpha Medical Honor Societies.

Hospitals 52

Hospitals Therapies Clinical Trials Molecular Biology 52

The Pharma Data

APRIL 27, 2021

About Roche Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. Moreover, for the twelfth consecutive year, Roche has been recognised as one of the most sustainable companies in the Pharmaceuticals Industry by the Dow Jones Sustainability Indices (DJSI). ref:Marini, C.

Treatment 40

Treatment Disease Pharmaceuticals Therapies 40